Cargando…
Prophylactic Hepatitis E Vaccines: Antigenic Analysis and Serological Evaluation
Hepatitis E virus (HEV) infection causes sporadic outbreaks of acute hepatitis worldwide. HEV was previously considered to be restricted to resource-limited countries with poor sanitary conditions, but increasing evidence implies that HEV is also a public health problem in developed countries and re...
Autores principales: | Li, Yike, Huang, Xiaofen, Zhang, Zhigang, Li, Shaowei, Zhang, Jun, Xia, Ningshao, Zhao, Qinjian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7020013/ https://www.ncbi.nlm.nih.gov/pubmed/31963175 http://dx.doi.org/10.3390/v12010109 |
Ejemplares similares
-
Current progress in the development of prophylactic and therapeutic vaccines
por: Li, Tingting, et al.
Publicado: (2022) -
Escherichia coli-derived virus-like particles in vaccine development
por: Huang, Xiaofen, et al.
Publicado: (2017) -
Hepatitis E Vaccine to Prevent Morbidity and Mortality During Epidemics
por: Nelson, Kenrad E., et al.
Publicado: (2014) -
Capsid destabilization and epitope alterations of human papillomavirus 18 in the presence of thimerosal
por: Huang, Xiaofen, et al.
Publicado: (2021) -
Antigenic determinants of hepatitis E virus and vaccine-induced immunogenicity and efficacy
por: Zhao, Qinjian, et al.
Publicado: (2012)